Jerry G. Blaivas is an American urologist and senior faculty at the Icahn School of Medicine at Mount Sinai in New York City and adjunct professor of Urology at SUNY Downstate Medical School in Brooklyn, as well as professor of clinical urology at College of Physicians and Surgeons, Columbia University and clinical professor of Urology at Weill Medical College of Cornell University. He has four patents pending, has received four research grants for which he served as the principal investigator, and served as a major in the United States Army assigned to the Walson Army Hospital. He additionally served as president for the Urodynamic Society (1992 â 1993).
Blaivas received his MD at Tufts University School of Medicine in 1968; his internship and residency in general surgery were at Boston City Hospital from 1968 to 1971. His residency in urology was at Tufts Medical Center from 1973 to 1976, and his certification is with the American Board of Urology, where he has also served as an examiner in 1978. Blaivas is married and has three children.
Blaivasâ research has concentrated on BPH, urinary incontinence, and vaginal mesh complications. His pending patents focus on technological applications of data capture and medical information system. He was Principal Investigator on three grants focused on multiple sclerosis and has been funded by the National Multiple Sclerosis Society. Two of the projects studied voiding disturbances. He has been active in classification systems for incontinence, detrusor-external sphincter dyssynergia, overactive bladder, urinary urgency, nocturia, bladder outlet obstruction in women and urethral strictures. Many of his peer-reviewed articles are on urethral reconstruction in women, and he has performed over 140 urethral reconstructions.
He was president of the Urodynamic Society (1992 â 1993), and founder and Editor-in-Chief of its journal Neurology and Urodynamics through 2007. In 1988, he founded (and is the medical director of) the Institute for Bladder and Prostate Research, a not-for-profit dedicated to research about treatment options for urological conditions, and is now their medical director. He is the Chief Scientific Officer for Symptelligence Medical Informatics. He is the chairman of three councils of the American Urological Association: the New Technology Council (1993 â 1997), the Biomedical Engineering Committee (1990 - 1993), and the Voiding Dysfunction Committee, (1996 - 2000)
Partial list:
His most-cited peer-reviewed articles according to Google Scholar: